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Summary
There is a solid theoretical basis for expecting climate change to have a considerable 
effect on the infectious diseases of humans, animals and plants. Vector-borne diseases 
are the most likely to be affected. It is, however, rare to observe such impacts, as 
diseases are also influenced by many other drivers, some of which may have stronger 
effects over shorter time scales than climate change. Nevertheless, there is evidence 
that our warming climate has already influenced some animal diseases, of which 
bluetongue is considered a prime example.
Bluetongue emerged dramatically in southern Europe after 1998 and in northern 
Europe from 2006. While the speed and scale of this emergence is a challenge to 
explain, there is evidence, principally from the development of climate-driven models, 
that recent climate change has played a significant role. Climate-driven models point 
to an increase in the risk of bluetongue transmission in Europe in recent decades, 
caused by an increased suitability of parts of southern Europe for the Afro-tropical 
biting midge, Culicoides imicola, as well as an increase in the vectorial capacity of 
indigenous Culicoides vectors in northern Europe. Farm-to-farm transmission models of 
bluetongue in England and Wales under predicted climatic conditions further suggest 
that, under high-emission scenarios, the scale of future outbreaks could far exceed 
those experienced to date. The role of climate change in the developing threat of 
animal disease is, therefore, likely to be economically and socially costly, unless lower 
emission targets can be set and followed.
Keywords
Basic reproduction number – Bluetongue – Climate change – Culicoides – Europe – Model – 
Vector-borne disease.
Introduction
Climate change is widely believed to be an important driver 
of the emergence and spread of infectious diseases (1, 2, 3, 
4, 5, 6) and, therefore, a major threat to human, animal and 
plant health. This belief comes from the observation that 
many diseases are sensitive to the effects of climate, coupled 
with the supposition that such diseases will therefore be 
affected as the climate changes.
The link between specific diseases and climate is strongly 
supported by the evidence. In general, climate affects diseases 
in five ways. It may limit the spatial distribution of a disease; 
for example, many vector-borne diseases are restricted to 
warmer parts of the world because climate constrains the 
geographic range of ectothermic insects and ticks. Second, 
it may influence the scale of outbreaks by affecting the 
survival and spread of pathogens in the environment or 
vectors. Third, it may affect seasonal disease occurrence. 
For example, the common cold and influenza tend to occur 
in winter because of indoor crowding, facilitating the rapid 
spread of viruses among people and, possibly, because of 
weaker immune systems. Fourth, climate may determine 
the years in which outbreaks of disease occur; the periodic 
occurrence of the El Niño Southern Oscillation (ENSO), 
for example, induces drought and more intense rainfall in 
various parts of the world, and these climatic changes are 
associated with outbreaks of many diseases. Finally, in some 
cases, climate may affect the clinical severity of disease in 
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the affected individual. This is most common for diseases 
whose severity is linked to the size of inoculum which, in 
turn, is affected by climate (parasites acquired from the 
environment, for example).
The scale of the link between climate and disease is 
formidable. Studies have found that about half (7) to 
two-thirds (8) of clinically important infectious diseases 
of humans and animals in Europe are sensitive to a range 
of climate variables. However, it is worth asking whether 
sensitivity to climate change is an inevitable consequence of 
sensitivity to climate variability. The answer is probably no. 
The seasonal occurrence of diseases such as influenza, for 
example, may not change significantly with climate change. 
It remains unclear whether periodic cycles occurring over 
shorter time scales, such as ENSO, will be affected by 
climate change. If not, then the many diseases susceptible 
to such cycles may not respond to climate change. There 
is, nevertheless, a strong theoretical basis for believing that 
many climate-sensitive diseases will respond, in one or more 
ways, to climate change. Systematic review has identified 
vector-borne diseases as particularly likely to be driven by 
climate, although water-, food-, soil- and air-borne diseases 
were also important (8). It is possible, therefore, that a 
variety of diseases, with a range of transmission routes, may 
respond to future climate change.
While many diseases may respond to climate change, it is 
arguable that in many, perhaps most, cases, we will not see 
the response. A major issue is that diseases are affected by a 
range of factors, called drivers, which affect their emergence 
or spread. Climate is just one of these (9). Other drivers 
are changes to the environment through deforestation 
and urbanisation; developments in agriculture and food 
production; changes in how people live, behave, eat, travel 
and trade; changes in human and veterinary medicine; 
public health; the use of antimicrobials and insecticides and 
the development of resistance to these; and the occurrence 
of ‘shocks’ such as war or famine. In a major review of the 
causes of over 300 human disease outbreaks over 65 years, 
climate was only implicated in ten: of these, six were water-
borne diseases, one was fungal and only three were insect-
borne (9).
Non-climate drivers may therefore be more important than 
climate drivers for the vast majority of diseases. Crucially, 
these non-climate drivers may also be changing far more 
rapidly than climate, so that any effects of climate change 
may get lost in the greater effects that other drivers have 
over the same time scale (10). Malaria presents an excellent 
example. While malaria is strongly sensitive to climate, 
and climate change is therefore expected to be a force 
in increasing its incidence or expanding its distribution 
in some tropical highland areas (11), in reality malaria 
is rapidly declining (12). This is as a result of a range of 
negative drivers – the integrated reduction of mosquito 
populations, the development of rapid diagnostic tests and 
prophylactic control of the malaria-carrying parasites.
These considerations have not stopped many researchers 
from developing models for the future distribution of 
infectious diseases, especially vector-borne diseases (or the 
vectors themselves), at future times and climates (11, 13, 
14, 15, 16, 17, 18, 19, 20, 21, 22, 23). These models are 
rarely able to include the influence of other drivers (though 
see 24, 25) for two main reasons. First, there is often little 
or no quantification of how change in a non-climate driver 
affects a disease; and second, there are rarely scenarios or 
models for how these non-climate drivers will change in the 
future (although human population size estimates are an 
exception). This contrasts with the relative ease of climate-
disease modelling: experimental or statistical studies can be 
used to associate levels of disease with weather or climate 
variables, and global climate models are used to project 
those or similar variables into the future. Combining the 
two allows levels or distributions of climate-sensitive 
diseases to be projected under future climate scenarios.
Given the importance of other drivers, it is perhaps not 
surprising that there is as yet little empirical evidence for 
the effects of climate change on diseases, despite the world 
approaching 1°C above pre-industrial temperatures. This 
was also the case for vector-borne diseases, 15 years ago 
(26). In recent years, however, a number of vector-borne 
diseases have emerged in different parts of the world, 
including dengue, Chikungunya, Zika, yellow fever, West 
Nile, tick-borne encephalitis, Lyme disease, Crimean-Congo 
haemorrhagic fever, bluetongue, epizootic haemorrhagic 
disease and Schmallenberg. The emergence of bluetongue 
in Europe has been particularly strongly attributed to 
climate change (18, 27). Given its position as the prime 
example, it is useful to look in detail at the evidence for 
and against this theory, as it provides us with information 
on the importance of climate change when considering the 
developing threat of emerging infectious diseases in general.
Bluetongue
Bluetongue is a disease of ruminants (cattle, sheep, deer) 
caused by bluetongue virus (BTV), which has more than 
25 serotypes. It was first discovered in South Africa in 
the early 20th century (28) and considered an African 
disease until 1943, when an outbreak occurred in Cyprus 
(29). Further outbreaks followed in the Middle East. Soon 
after, it was discovered that the virus was present in North 
America and, later, in South Asia and Australia. After the 
initial outbreak in Cyprus, there were two further outbreaks 
in Europe before the turn of the century. The first was a 
severe outbreak of serotype 10 (BTV-10) between 1956 and 
1960 in southern Iberia (Spain and Portugal). The second 
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was an outbreak of BTV-4 from 1979 to 1980, at the other 
end of the Mediterranean Sea, on the Greek islands of 
Lesbos and Rhodes, close to the west coast of Turkey.
BTV-4 then reappeared another 20 years later (1998), also on 
the Greek islands. This time, however, the outbreak heralded 
the start of the biggest bluetongue outbreak seen to date. 
Over the ensuing few years, southern Europe was invaded 
by several different serotypes of BTV (most notably: 1, 2, 
4, 9 and 16). These incursions occurred in many countries 
that had never experienced bluetongue before and 800 km 
further north than had been previously reported (30). 
Then, in 2006, BTV-8 appeared unexpectedly in northern 
Europe and, over the next three years, spread over a huge 
area of the continent, including the United Kingdom (UK) 
and reaching southern Scandinavia (31). The outbreak of 
BTV-8 alone affected hundreds of thousands of farms, at a 
huge financial cost (an estimated €164–175 million in the 
Netherlands in 2007 alone) (32), until it was brought to a 
stop with a newly developed vaccine.
Eighteen years after the start of these unprecedented 
bluetongue outbreaks, BTVs are still circulating in Europe. 
In 2015, BTV-1, 2, 4, 8 and 16 were all detected in different 
parts of the continent and, as of 2016, BTV-8 had spread 
significantly through France and threatened the UK once 
more.
Therefore, after most of a century in which only three 
bluetongue outbreaks were recorded in the southern 
corners of Europe, the last 18 years have seen an upsurge in 
the disease’s epidemiology in the region.
Vector transmission of 
bluetongue virus in Europe
The historical distribution of BTV in Europe before the 
recent outbreak was almost identical to that of the Afro-
tropical species of biting midge, Culicoides imicola. This 
species occurs throughout sub-Saharan Africa where it is 
the major vector of BTV. Its distribution extends to North 
Africa, the Middle East and southern Asia, as far east as 
Viet Nam, as well as into Europe. Before the 1998 outbreak, 
it was known only from southern Spain (33) and Portugal 
(34), Cyprus (35) and the Greek islands of Rhodes (36) 
and Lesbos (37), as mentioned above. It is important to 
recognise that many of these surveys were undertaken 
in response to outbreaks of bluetongue. Few surveys of 
Culicoides in southern Europe were published in regions 
that had not experienced the disease, although one survey 
of Spain in the early 1990s failed to record a single C. imicola 
at over 30 sites in the northern half of the country (38). 
Remarkably, a survey of the Culicoides of Morocco in 1970 
recorded C. imicola (under its old name, C. pallidipennis) in 
the south of France (39); but when an author (M. Kremer) 
was asked about this in the early 1990s (by M. Baylis), he 
described it as a mistake.
The outbreak that began in 1998 occurred over a much 
larger area of southern Europe, including mainland Greece, 
mainland Italy, Sicily, Sardinia and the French island of 
Corsica. Culicoides imicola was subsequently found in all 
of these regions, suggesting an expansion of its distribution.
Bluetongue (serotype 9) also occurred extensively in 
Bulgaria from 1999; yet, in a survey of 119 farms and 
300 trap-nights, and catching more than 70,000 Culicoides, 
not a single C. imicola was caught (40). Instead, catches were 
dominated by the Palearctic C. obsoletus and C. pulicaris 
groups. These species groups had, in fact, previously 
been implicated as possible vectors of BTV. In 1979, 
BTV-4 was isolated from Cypriot C. obsoletus (41), and the 
closely related African horse sickness virus, serotype 4, 
was isolated from mixed pools of the two species groups 
(and one to two other species of Culicoides) from Spain in 
1988 (42). These species groups occur throughout Europe 
and, as immediately recognised in 1979, the findings were 
potentially important for mainland Europe and the UK (41). 
These field isolations were accompanied by demonstrations 
showing that wild-caught individuals of both species groups 
could also be infected with BTV by membrane feeding in 
the laboratory (43). In the period after 2006, many studies 
have provided strong evidence for the role of both species 
groups in the transmission of BTV-8 in northern Europe, 
as well as the transmission of other serotypes, both outside 
and inside (44, 45) the range of C. imicola.
Evidence for the role of climate 
change in the European 
emergence of bluetongue
The emergence of bluetongue in Europe appears to have 
been underpinned by three developments: first, incursions 
by multiple serotypes of the virus; second, a wider 
distribution of C. imicola than was previously known; and 
third, effective transmission of BTV, most clearly in northern 
Europe, by indigenous species of Culicoides, such as the 
obsoletus and pulicaris groups.
Evidence has been presented that climate change was a factor 
in this emergence. Temperature is critically important for 
the Culicoides life cycle and for the development of BTV 
within adult midges. It was argued that bluetongue’s 
incidence in the first years of its emergence was most 
marked where European temperature had increased the 
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most between the 1980s to 1990s (27). This assessment was 
made, however, before bluetongue occurred over a huge 
area of northern Europe, and no evidence was presented 
that the degree of warming was sufficient to explain the 
dramatic emergence in the south.
A more detailed exploration of the possible role of climate 
change in Europe used a mathematical model that described 
the risk (based on R0, the basic reproduction number) of 
bluetongue transmission. The model included four climate-
sensitive variables: 
– the number of C. imicola and C. obsoletus group midges 
– their longevity 
– their biting rate 
– the time required for a midge to become infectious 
after taking an infected blood meal (termed the extrinsic 
incubation period or EIP). 
The last three combine to describe the average number 
of blood meals taken by a midge on a suitable host during 
the portion of its life for which it is infectious; 
this combination is a measure of the risk of virus 
transmission by infectious midges. The model was run 
using observed climate data for Europe from 1961 to 
2009, and using modelled climate data up to 2050, 
based on 11 regional climate models driven by the 
IPCC Special Report on Emissions Scenarios 1B emission 
scenario (46).
The model suggests that there was an increase in the risk 
of bluetongue transmission in much of western Europe in 
the 1990s and from 2000 to 2009 (Figs 1a & 1b), relative 
to the long-term average (1960–2009). It then provides 
some insight into possible explanations. First, the increase 
in risk in south-western Europe is consistent with a recent 
increase in the suitability of much of southern Europe 
for C. imicola (Fig. 1c); and second, the increase in risk 
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Fig. 1.  
Modelled impact of climate on the risk of bluetongue or its vectors
All figures show anomalies for the stated time period relative to the 1961–2009 long-term average. Adapted from (18), updated with more recent climate 
data from E-OBS version 11
a) Basic reproduction number anomaly for 1990–1999 
c) Culicoides imicola vector-to-host ratio anomaly  
for 2000–2009
b) Basic reproduction number anomaly for 2000–2009
d) Percentage change in extrinsic incubation rate of 
bluetongue virus in Culicoides
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in north-western Europe is consistent with a temperature-
associated increase in the rate of virus replication (Fig. 1d).
There is a dramatic increase in transmission risk in north-
western Europe, relative to the long-term average, from 
the mid-1990s onwards (Fig. 2a). Remarkably, the year 
of highest risk, out of the previous 50, was 2006, which 
was the year that bluetongue first appeared in the region. 
An increasing transmission risk over time is also apparent 
in south-western Europe (Fig. 2b). Interestingly, all three 
outbreaks of midge-borne disease in south-western Europe 
since 1960 (African horse sickness in 1965–1966 and 
1987–1990, and bluetongue from 2000–2006) occurred 
during periods of positive anomaly in transmission risk.
In the authors’ view, these results provide the strongest 
evidence to date that recent changes to climate have played a 
role in the emergence of bluetongue in Europe. Specifically, 
they show that climate variability affects the risk of virus 
transmission by Culicoides in Europe and that recent climate 
change has increased that risk. They indicate that disease 
outbreaks in Europe occur during periods of high risk 
induced by favourable climatic conditions. They suggest 
that the changing climate has increased the suitability 
of southern Europe for the exotic vector C. imicola; and 
increased the ability of native vectors (especially the 
C. obsoletus group) to transmit the virus, in particular by 
shortening the EIP, over northern Europe.
Evidence from other sources
It is important to ask whether these inferences from models 
are supported by empirical observation. Specifically, has 
C. imicola recently spread in southern Europe, and are the 
C. obsoletus group more able to transmit BTV than they were 
before?
There is clear evidence from entomological surveys that 
C. imicola has recently colonised at least three areas: 
Catalonia in north-eastern Spain (47), the Var region of 
southern mainland France (48), and the north Pyrenees 
region, also in mainland France (49). These areas of 
range expansion largely agree with the modelled outputs. 
Figure 1c shows increased suitability for C. imicola around 
the Mediterranean coast of France, extending west along the 
Pyrenees and touching Catalonian Spain. However, a suite 
of recent genetic population studies has demonstrated that 
C. imicola is anything but a new arrival in the Mediterranean 
region (50, 51, 52) – in fact, it appears to have been present 
for thousands of years (50). C. imicola may have existed in 
southern Europe in isolated populations that, in the absence 
of midge-borne diseases, managed to avoid detection (except, 
perhaps, by 39). Recent climate change may then have 
facilitated range expansion of these existing populations at the 
extremes of their range, but cannot be credited with the initial 
introduction of C. imicola into the region. There is no evidence 
to address the question of whether the C. obsoletus group 
in northern Europe has increased in vectorial capacity as a 
result of climate change since, before 2006, hardly any studies 
were undertaken on the ability of this species to transmit 
viruses. It is interesting to observe that, in the same period that 
BTV-8 was spreading through northern Europe, a second 
BTV serotype (BTV-1) spread northwards from southern 
Europe (53), reaching Brittany in northern France by 
November 2008 and affecting over 4,000 farms (48). 
The C. obsoletus group dominates Culicoides catches in the 
region (48). 
Three years later, northern European C. obsoletus (54) were 
identified as major vectors of a novel Orthobunyavirus, 
called Schmallenberg virus (SBV), that appeared suddenly 
in Germany in the summer of 2011 (55) and spread rapidly 
across the continent (56). SBV causes negligible clinical 
disease in adult cattle and sheep and is therefore difficult to 
detect at the time of spread; however, it is able to damage 
developing fetuses when female animals are infected early 
in pregnancy. In late 2011 and 2012–2013, northern 
Europe experienced a devastating wave of abortions and 
birth defects in both cattle and sheep caused by SBV.
There have, therefore, been at least three separate 
occurrences of arbovirus transmission by C. obsoletus group 
midges in northern Europe in the last decade, while there is 
no evidence of any transmission in the region in the previous 
100 years. It appears that something has changed recently 
– but what? The increase in vectorial capacity in recent 
years (Fig. 2a) in models driven by observed climate data 
suggests that recent climate change should be considered 
a likely cause, although this cannot be considered proven.
Impact of climate change 
on outbreak dynamics
Models suggest that climate change will continue to 
increase the risk of bluetongue outbreaks in the future (18). 
It is useful to ask how severe future outbreaks might be 
(in terms of incidence, duration, rate of spread, etc.), in 
comparison to those of today, and what additional measures 
might therefore be required to control them. Addressing 
such questions requires a different modelling approach; 
namely, full transmission models.
Full transmission models describe the spread of infection 
between individuals or, in the case of livestock, between 
farms. A stochastic transmission model for bluetongue 
in the UK (57) describes the spread of infection between 
farms by both the movement of infected cattle or sheep 
(if not yet detected in these animals), and by the dispersal of 
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Fig. 2 
Standardised anomalies of a reduced model of the basic reproduction number of bluetongue in a) north-western and b) south-western 
Europe
The reduced model describes the ability of the average Culicoides vector to transmit the virus (combining longevity, biting rate and extrinsic incubation 
period) but does not include dynamic vector-to-host ratio
Red bars are positive anomalies, indicating higher-than-average transmission ability 
Blue bars are negative anomalies, indicating lower-than-average transmission ability 
Stars and circles show years of recorded occurrence of Culicoides-borne diseases (bluetongue or African horse sickness) in the region
Adapted from (18), updated with more recent climate data from E-OBS version 1
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infected Culicoides between farms. The model incorporates 
the effects of temperature in determining the number of 
midges present on a farm, and their vectorial capacity (thus 
affecting a farm’s ‘infectiousness’).
With this modelling framework, it is possible to explore 
the potential scale of outbreaks in different years, according 
to their various recorded temperatures, and also to 
explore the potential outbreak scale under future climates. 
Figure 3 summarises the scale of simulated outbreaks, 
following the seeding of infection into a single farm in 
the south of England, under the recorded temperatures of 
2006, 2007 and 2014 (58). Potential outbreak scales are 
seen to vary significantly from year to year, depending on 
temperature conditions. Figure 3 also shows that 2006 was 
much more favourable for bluetongue in the UK than 2007. 
2006 was the year of introduction of BTV-8 into northern 
Europe and it reached the UK in 2007; the less favourable 
temperature conditions that year may have prevented a 
larger outbreak in the UK.
The model further shows that the scale of future outbreaks may 
be similarly large or larger. Under a scenario of medium low 
emissions, the representative concentration pathway (RCP) 
4.5 emission scenario (Scenario A) (59), the average 
outbreak size at the end of the current century is slightly 
smaller than that simulated for 2006, but much larger than 
that in 2007. Under a higher RCP 8.5 emission scenario, 
and employing extremes of temperature (Scenario B), 
the scale of an outbreak at the end of the century is, on 
average, more than two times larger than that simulated 
for 2006. Indeed, the 95th percentile of outbreak sizes in 
2006 is less than the 25th percentile in Scenario B. These 
simulations show that under future climate conditions the 
UK will not only be at greater risk of bluetongue outbreaks, 
but outbreaks that occur will be substantially larger than 
equivalent outbreaks would be today, and more stringent 
measures may be required to control them.
Conclusions
The extremely rapid and dramatic emergence of bluetongue 
in Europe between 1998 and 2008 remains a challenge to 
explain. The abrupt transition from periodic epizootics in 
the southern corners of Europe to regular viral invasions, 
continent-wide transmission, and a state of endemicity, 
cannot readily be accounted for. Nevertheless, modelling 
suggests that warming in Europe in recent decades has 
played a role, allowing C. imicola to expand beyond its range 
and indigenous Culicoides to increase in vectorial capacity.
Modelling suggests that the risk of bluetongue will increase 
in the future, as the climate continues to warm; and other 
Culicoides-borne diseases, such as African horse sickness 
and epizootic haemorrhagic disease, will probably increase 
in risk too. Transmission modelling indicates that future 
outbreaks (at least in northern Europe), when they happen, 
should also be expected to be substantially larger than 
those experienced so far, but also that this largely depends 
on the emission scenario. This is an important message for 
policy-makers: pursuing lower emission targets can lead to 
financial benefits from smaller, less frequent animal disease 
outbreaks.
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L’influence du changement climatique dans les menaces sanitaires 
évolutives : l’exemple de la fièvre catarrhale ovine en Europe
M. Baylis, C. Caminade, J. Turner & A.E. Jones
Résumé
Nombre d’arguments théoriques sérieux confirment l’ampleur des effets du 
changement climatique sur les maladies infectieuses affectant l’être humain, 
les animaux et les végétaux. Les maladies à transmission vectorielle sont 
probablement les plus sujettes à cette influence. Toutefois, il est très rare de 
pouvoir observer ces effets directement, dans la mesure où d’autres facteurs 
exercent également une influence sur les maladies, dont certains ont des effets 
plus marquants et plus rapides que le changement climatique. L’influence du 
réchauffement climatique sur certaines maladies animales a néanmoins été 
prouvée ; à ce titre, le cas de la fièvre catarrhale ovine est considéré comme 
exemplaire.
La fièvre catarrhale ovine a fait son apparition en Europe méridionale après 1998, 
puis en Europe du Nord à partir de 2006. Si la rapidité et l’envergure de cette 
émergence sont difficiles à expliquer, plusieurs démonstrations, recourant pour 
la plupart à des modèles axés sur le climat font état du rôle important joué par le 
changement climatique. Les modèles axés sur le climat font ressortir un risque 
accru de transmission de la fièvre catarrhale ovine en Europe au cours des 
dernières décennies, associé, d’une part, à l’adéquation croissante de régions 
entières de l’Europe méridionale vis-à-vis du moucheron afro-tropical Culicoides 
imicola et, d’autre part, à l’accroissement de la capacité vectorielle des vecteurs 
Culicoides autochtones dans le nord de l’Europe. D’après les études basées sur 
des modèles de transmission de la fièvre catarrhale ovine entre exploitations 
en Angleterre et au Pays de Galles, dans les conditions climatiques prévisibles, 
il apparaît qu’en cas de fortes émissions, l’ordre de grandeur des foyers futurs 
serait considérablement plus élevé que dans les épisodes que nous avons 
connus jusqu’à présent. Par conséquent, le rôle du changement climatique dans 
les menaces évolutives de santé animale risque d’avoir un coût économique et 
social élevé, à moins que des objectifs de réduction de l’émission soient mis en 
place et fassent l’objet d’un suivi approprié.
Mots-clés
Changement climatique – Culicoides – Europe – Fièvre catarrhale ovine – 
Maladie à transmission vectorielle – Modèle – Taux de reproduction de base.
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Resumen
Existen sólidas bases teóricas para prever que el cambio climático tendrá 
efectos considerables en las enfermedades infecciosas que afectan al hombre, 
los animales o las plantas. Las que más probablemente se verán afectadas son 
las enfermedades transmitidas por vectores. Sin embargo, rara vez pueden 
observarse tales efectos, pues hay otros muchos factores que influyen en las 
enfermedades, algunos de los cuales, a una escala temporal más breve, pueden 
tener una influencia más marcada que el cambio climático. Aun así, hay pruebas 
de que el clima, en pleno proceso de calentamiento, ya ha incidido en algunas 
enfermedades animales, de las que la lengua azul se considera un perfecto 
ejemplo.
La lengua azul hizo una espectacular aparición en el sur de Europa a partir de 
1998, y en la Europa septentrional a partir de 2006. Aunque resulta difícil explicar la 
velocidad y las proporciones de tal aparición, existen sólidos indicios, obtenidos 
principalmente de la elaboración de modelos regidos por variantes climáticas, 
de que el reciente cambio climático ha cumplido una función importante. Estos 
modelos apuntan a un incremento del riesgo de transmisión de la lengua azul 
en Europa en los últimos decenios, lo que se explica por las condiciones más 
propicias al jején afrotropical, Culicoides imicola, que ofrecen ciertas partes de 
Europa meridional y por un aumento de la capacidad vectorial de los Culicoides 
autóctonos del norte de Europa. Los modelos de transmisión de la lengua azul 
entre explotaciones agropecuarias de Inglaterra y Gales en las condiciones 
climáticas predichas indican además que, en la hipótesis de un elevado volumen 
de emisiones, los futuros brotes pueden revestir una escala muy superior a 
cuanto hemos conocido hasta ahora. Por consiguiente, a menos que se logre 
establecer y cumplir objetivos de emisiones menos cuantiosas, es probable que 
el cambio climático resulte económica y socialmente gravoso por su incidencia 
en la creciente amenaza que plantean las enfermedades animales.
Palabras clave
Cambio climático – Culicoides – Enfermedad transmitida por vectores – Europa – Lengua 
azul – Modelo – Número básico de reproducción.
La influencia del cambio climático en una amenaza creciente:  
el caso de la lengua azul en Europa
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